Cargando…
HC-1119, a deuterated Enzalutamide, inhibits Migration, Invasion and Metastasis of the AR-positive triple-negative breast Cancer cells
Triple-negative breast cancers (TNBCs) are aggressive, and they develop metastasis at earlier stages, relapse more frequently, and exhibits poorer prognosis than other subtypes of breast cancer. Due to the lack of estrogen receptor for endocrine therapy and HER2 for targeted therapy, new targeted th...
Autores principales: | Wu, Xuehong, Feng, Wanru, Yang, Mao, Liu, Xunxi, Gao, Mengdi, Li, Xinghai, Gan, Lin, He, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515013/ https://www.ncbi.nlm.nih.gov/pubmed/35960413 http://dx.doi.org/10.1007/s11033-022-07749-8 |
Ejemplares similares
-
Effect of N-methyl deuteration on metabolism and pharmacokinetics of enzalutamide
por: Jiang, Jinfang, et al.
Publicado: (2016) -
Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC
por: White, Ralph E., et al.
Publicado: (2023) -
Phase I clinical trial of HC‐1119 soft capsule in Chinese healthy adult male subjects: Pharmacokinetics and safety of single‐dose proportionality and effects of food
por: Ma, Haiping, et al.
Publicado: (2021) -
Plasma AR Copy Number Changes and Outcome to Abiraterone and Enzalutamide
por: Gurioli, Giorgia, et al.
Publicado: (2020) -
A noncanonical AR addiction drives enzalutamide resistance in prostate cancer
por: He, Yundong, et al.
Publicado: (2021)